Join Us

We are 225,038 members in 83 forums discussing 163,853 topics.

Help with Abbreviations

Topic: Piqray Improves Overall Survival for Adv. HR+, HER2- PIK3CA+

Forum: Stage IV/Metastatic Breast Cancer, Open to All To Contribute —

Topics here are started by members with a Stage IV/Metastatic Breast Cancer diagnosis, but open to all members to contribute to discussions. Please note that there is a separate forum, Stage IV/Metastatic Breast Cancer ONLY, where topics are open only to those members.

Posted on: Oct 23, 2020 03:28PM

Moderators wrote:

Piqray Improves Overall Survival for Advanced-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer With PIK3CA Mutation
October 16, 2020

Postmenopausal women and men diagnosed with advanced-stage hormone-receptor-positive, HER2-negative breast cancer with a PIK3CA mutation lived about 8 months longer when treated with the combination of the targeted therapy Piqray and the hormonal therapy Faslodex compared to Faslodex alone. Read more...

To send a Private Message to the Mods:
Log in to post a reply